Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa [Phase 1]

View source ↗

Summary

This clinical trial update indicates a Phase 1 study to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa | Phase 1 | Status: RECRUITING